Related references
Note: Only part of the references are listed.Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology
Anette Lykke Petri et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2009)
Influence of tumor stage, symptoms, and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer
Miquel Porta et al.
CANCER CAUSES & CONTROL (2009)
Overinterpretation of Clinical Applicability in Molecular Diagnostic Research
Blanca Lumbreras et al.
CLINICAL CHEMISTRY (2009)
Omics data and levels of evidence for biomarker discovery
Debashis Ghosh et al.
GENOMICS (2009)
Multicenter Validation of a 1,550-Gene Expression Profile for Identification of Tumor Tissue of Origin
Federico A. Monzon et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Defining the scientific method
[Anonymous]
NATURE METHODS (2009)
Quality and Reporting of Diagnostic Accuracy Studies in TB, HIV and Malaria: Evaluation Using QUADAS and STARD Standards
Patricia Scolari Fontela et al.
PLOS ONE (2009)
Sources of error and its control in studies on the diagnostic accuracy of -omics technologies
Blanca Lumbreras et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
QUADOMICS: An adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of '-omics'-based technologies
Blanca Lumbreras et al.
CLINICAL BIOCHEMISTRY (2008)
Validation of Biomarker-Based Risk Prediction Models
Jeremy M. G. Taylor et al.
CLINICAL CANCER RESEARCH (2008)
Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids
Miquel Porta et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design
David F. Ransohoff
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer
Claudio Belluco et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Timing of blood extraction in epidemiologic and proteomic studies:: results and proposals from the PANKRAS II Study
Miquel Porta et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2007)
Diagnostic pathology and laboratory medicine in the age of Omics - A paper from the 2006 William Beaumont Hospital Symposium on molecular pathology
William G. Finn
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Is molecular profiling ready for use in clinical decision making?
John P. A. Ioannidis
ONCOLOGIST (2007)
The quality of diagnostic accuracy studies since the STARD statement - Has it improved?
N. Smidt et al.
NEUROLOGY (2006)
Identification of potential CSF biomarkers in ALS
GM Pasinetti et al.
NEUROLOGY (2006)
Challenges in systematic reviews of diagnostic technologies
A Tatsioni et al.
ANNALS OF INTERNAL MEDICINE (2005)
Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer
KA Baggerly et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Opinion - Bias as a threat to the validity of cancer molecular-marker research
DF Ransohoff
NATURE REVIEWS CANCER (2005)
Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments
KA Baggerly et al.
BIOINFORMATICS (2004)
Sources of variation and bias in studies of diagnostic accuracy - A systematic review
P Whiting et al.
ANNALS OF INTERNAL MEDICINE (2004)
Internal and external validation of predictive models: A simulation study of bias and precision in small samples
EW Steyerberg et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration
PM Bossuyt et al.
CLINICAL CHEMISTRY (2003)
The promise of biomarkers in cancer screening and detection
RS Negm et al.
TRENDS IN MOLECULAR MEDICINE (2002)
Evidence base of clinical diagnosis - The architecture of diagnostic research
DL Sackett et al.
BRITISH MEDICAL JOURNAL (2002)
Use of proteomic patterns in serum to identify ovarian cancer
EF Petricoin et al.
LANCET (2002)
Share Paper
